[PDF][PDF] Outsourcing of pharmaceutical Manufacturing–a strategic partner selection process
G Festel, M De Nardo… - Journal of Business …, 2014 - businesschemistry.org
The outlook for the pharmaceutical industry is promising (Ernst & Young 2010; Price
Waterhouse Coopers 2011). The 2009 market of $775 billion US-Dollar is expected to grow …
Waterhouse Coopers 2011). The 2009 market of $775 billion US-Dollar is expected to grow …
[PDF][PDF] Outsourcing of Pharmaceutical Manufacturing–A Strategic Partner Selection Process
G Festel, M De Nardo, T Simmen - Letter from the Editor, 2014 - businesschemistry.org
The outlook for the pharmaceutical industry is promising (Ernst & Young 2010; Price
Waterhouse Coopers 2011). The 2009 market of $775 billion US-Dollar is expected to grow …
Waterhouse Coopers 2011). The 2009 market of $775 billion US-Dollar is expected to grow …
[PDF][PDF] Outsourcing of Pharmaceutical Manufacturing–A Strategic Partner Selection Process
G Festel, M De Nardo, T Simmen - Journal of Business …, 2014 - scholar.archive.org
The outlook for the pharmaceutical industry is promising (Ernst & Young 2010; Price
Waterhouse Coopers 2011). The 2009 market of $775 billion US-Dollar is expected to grow …
Waterhouse Coopers 2011). The 2009 market of $775 billion US-Dollar is expected to grow …
Outsourcing of Pharmaceutical Manufacturing-A Strategic Partner Selection Process.
G Festel, M De Nardo… - Journal of Business …, 2014 - search.ebscohost.com
The pharmaceutical industry is a growing industry, but companies struggle to capitalize on
this growth because of a variety of challenges: shortening patent lives, strong pressure on …
this growth because of a variety of challenges: shortening patent lives, strong pressure on …